Asunto(s)
Lepra Lepromatosa/diagnóstico , Neuralgia/fisiopatología , Enfermedades del Sistema Nervioso Autónomo/diagnóstico , Diagnóstico Diferencial , Trastornos de Cefalalgia/diagnóstico , Humanos , Lepra Lepromatosa/tratamiento farmacológico , Lepra Lepromatosa/patología , Lepra Lepromatosa/fisiopatología , Masculino , Adulto JovenRESUMEN
BACKGROUND: Leprosy reactions are a significant cause of morbidity in leprosy population. Erythema nodosum leprosum (ENL) is an immunological complication affecting approximately 50% of patients with lepromatous leprosy (LL) and 10% of borderline lepromatous (BL) leprosy. ENL is associated with clinical features such as skin lesions, neuritis, arthritis, dactylitis, eye inflammation, osteitis, orchitis, lymphadenitis and nephritis. ENL is treated mainly with corticosteroids and corticosteroids are often required for extended periods of time which may lead to serious adverse effects. High mortality rate and increased morbidity associated with corticosteroid treatment of ENL has been reported. For improved and evidence-based treatment of ENL, documenting the systems affected by ENL is important. We report here the clinical features of ENL in a cohort of patients with acute ENL who were recruited for a clinico-pathological study before and after prednisolone treatment. MATERIALS AND METHODS: A case-control study was performed at ALERT hospital, Ethiopia. Forty-six LL patients with ENL and 31 non-reactional LL matched controls were enrolled to the study and followed for 28 weeks. Clinical features were systematically documented at three visits (before, during and after predinsolone treatment of ENL cases) using a specifically designed form. Skin biopsy samples were obtained from each patient before and after treatment and used for histopathological investigations to supplement the clinical data. RESULTS: Pain was the most common symptom reported (98%) by patients with ENL. Eighty percent of them had reported skin pain and more than 70% had nerve and joint pain at enrolment. About 40% of the patients developed chronic ENL. Most individuals 95.7% had nodular skin lesions. Over half of patients with ENL had old nerve function impairment (NFI) while 13% had new NFI at enrolment. Facial and limb oedema were present in 60% patients. Regarding pathological findings before treatment, dermal neutrophilic infiltration was noted in 58.8% of patients with ENL compared to 14.3% in LL controls. Only 14.7% patients with ENL had evidence of vasculitis at enrolment. CONCLUSION: In our study, painful nodular skin lesions were present in all ENL patients. Only 58% patients had dermal polymorphonuclear cell infiltration showing that not all clinically confirmed ENL cases have neutrophilic infiltration in lesions. Very few patients had histological evidence of vasculitis. Many patients developed chronic ENL and these patients require inpatient corticosteroid treatment for extended periods which challenges the health service facility in resource poor settings, as well as the patient's quality of life.
Asunto(s)
Eritema Nudoso/patología , Eritema Nudoso/fisiopatología , Lepra Lepromatosa/patología , Lepra Lepromatosa/fisiopatología , Piel/patología , Adolescente , Corticoesteroides/efectos adversos , Corticoesteroides/uso terapéutico , Adulto , Biopsia , Estudios de Casos y Controles , Edema/etiología , Eritema Nudoso/tratamiento farmacológico , Etiopía/epidemiología , Extremidades , Femenino , Hospitales , Humanos , Lepra Dimorfa/complicaciones , Lepra Lepromatosa/complicaciones , Lepra Lepromatosa/microbiología , Masculino , Persona de Mediana Edad , Infiltración Neutrófila , Dolor , Calidad de Vida , Piel/efectos de los fármacos , Piel/inmunología , Piel/microbiología , Vasculitis/etiología , Vasculitis/patología , Adulto JovenRESUMEN
Leprosy or Hansen's disease is a chronic infectious disease of the skin and nerves, caused by the intracellular bacilli Mycobacterium leprae. It is characterized by a spectrum of clinical forms depending on the host's immune response to M. leprae. Patients with tuberculoid (TT) leprosy have strong cell-mediated immunity (CMI) with elimination of the bacilli, whereas patients with lepromatous (LL) leprosy exhibit defective CMI to M. leprae. Despite advances in the understanding of the pathogenesis of leprosy and the development of new therapeutic strategies, there is a need for the identification of biomarkers which be used for early diagnosis and to discrimination between different forms of the disease, as prognostic markers. Here, we analyzed the serum levels of IL-1ß, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL-17A, IFN-γ and TNF in order to address the contribution of these cytokines in late phase of M. leprae infection, and the impact of multidrug therapy (MDT). Our results demonstrated that patients of LL group presented higher expression of serum levels of inflammatory cytokines before MDT, while TT patients presented a balance between inflammatory and regulatory cytokines. MDT changes the profile of serum cytokines in M. leprae infected patients, as evidenced by the cytokine network, especially in TT patients. LL patients displayed a multifaceted cytokine system characterized by strong connecting axes involving inflammatory/regulatory molecules, while TT patients showed low involvement of regulatory cytokines in network overall. Cytokines can be identified as good biomarkers of the impact of MDT on the immune system and the effectiveness of treatment.
Asunto(s)
Citocinas/sangre , Lepra Lepromatosa/tratamiento farmacológico , Lepra Lepromatosa/inmunología , Biomarcadores/sangre , Quimioterapia Combinada , Humanos , Inmunidad Celular , Interferón gamma/sangre , Interleucina-10/sangre , Interleucina-12/sangre , Interleucina-13/sangre , Lepra Lepromatosa/sangre , Lepra Lepromatosa/fisiopatología , Mycobacterium leprae/efectos de los fármacos , Mycobacterium leprae/inmunologíaAsunto(s)
Células de la Médula Ósea/patología , Macrófagos/patología , Infecciones por Mycobacterium no Tuberculosas/patología , Adulto , Biopsia , Células de la Médula Ósea/inmunología , Células de la Médula Ósea/microbiología , Brasil , Femenino , Hospitales de Enseñanza , Humanos , Lepra Lepromatosa/inmunología , Lepra Lepromatosa/microbiología , Lepra Lepromatosa/patología , Lepra Lepromatosa/fisiopatología , Macrófagos/inmunología , Macrófagos/microbiología , Infecciones por Mycobacterium no Tuberculosas/inmunología , Infecciones por Mycobacterium no Tuberculosas/microbiología , Infecciones por Mycobacterium no Tuberculosas/fisiopatología , Mycobacterium leprae/inmunología , Mycobacterium leprae/aislamiento & purificación , Pancitopenia/etiología , Piel/inmunología , Piel/microbiología , Piel/patología , Piel/fisiopatología , Enfermedades Cutáneas Bacterianas/inmunología , Enfermedades Cutáneas Bacterianas/microbiología , Enfermedades Cutáneas Bacterianas/patología , Enfermedades Cutáneas Bacterianas/fisiopatologíaRESUMEN
Leprosy is a chronic granulomatous infection of skin and peripheral nerves caused by Mycobacterium leprae and is considered the main infectious cause of disability worldwide. Despite the several studies regarding leprosy, little is known about its effects on microvascular structure and function in vivo. Thus, we have aimed to compare skin capillary structure and functional density, cutaneous vasomotion (spontaneous oscillations of arteriolar diameter), which ensures optimal blood flow distribution to skin capillaries) and cutaneous microvascular blood flow and reactivity between ten men with lepromatous leprosy (without any other comorbidity) and ten age- and gender-matched healthy controls. Orthogonal polarization spectral imaging was used to evaluate skin capillary morphology and functional density and laser Doppler flowmetry to evaluate blood flow, vasomotion and spectral analysis of flowmotion (oscillations of blood flow generated by vasomotion) and microvascular reactivity, in response to iontophoresis of acetylcholine and sodium nitroprusside. The contribution of different frequency components of flowmotion (endothelial, neurogenic, myogenic, respiratory and cardiac) was not statistically different between groups. However, endothelial-dependent and -independent vasodilatations elicited by acetylcholine and sodium nitroprusside iontophoresis, respectively, were significantly reduced in lepromatous leprosy patients compared to controls, characterizing the existence of microvascular dysfunction. These patients also presented a significant increase in the number of capillaries with morphological abnormalities and in the diameters of the dermal papilla and capillary bulk when compared to controls. Our results suggest that lepromatous leprosy causes severe microvascular dysfunction and significant alterations in capillary structure. These structural and functional changes are probably induced by exposure of the microvascular bed to chronic inflammation evoked by the Mycobacterium leprae.
Asunto(s)
Capilares/fisiopatología , Lepra Lepromatosa/fisiopatología , Microcirculación , Enfermedades Cutáneas Bacterianas/fisiopatología , Piel/irrigación sanguínea , Acetilcolina/administración & dosificación , Adulto , Estudios Transversales , Femenino , Humanos , Iontoforesis , Flujometría por Láser-Doppler , Lepra Lepromatosa/diagnóstico , Masculino , Mycobacterium leprae/aislamiento & purificación , Nitroprusiato/administración & dosificación , Flujo Sanguíneo Regional , Piel/fisiopatología , Enfermedades Cutáneas Bacterianas/diagnóstico , VasodilataciónRESUMEN
With the world's focus on reducing the leprosy patient load to the extent of elimination, finding and reporting the rarer presentations of leprosy becomes important for prompt treatment. Also, these untreated patients may serve as a potential source of infection in community. We report a 35-year old man diagnosed to have lepromatous leprosy and erythema nodosum leprosum with inguinal lymph node abscess and suspected cardiac involvement that proved fatal. We stress the importance of detailed workup to look for associated systemic involvement for timely intervention and favourable outcome.
Asunto(s)
Eritema Nudoso/diagnóstico , Corazón/fisiopatología , Lepra Lepromatosa/diagnóstico , Ganglios Linfáticos/patología , Absceso , Adulto , Eritema Nudoso/patología , Eritema Nudoso/fisiopatología , Humanos , Lepra Lepromatosa/patología , Lepra Lepromatosa/fisiopatología , MasculinoRESUMEN
The histopathology of lepromatous skin varies according to the cell-mediated immunity of the host against Mycobacterium leprae. In tuberculoid and borderline tuberculoid leprosy, epithelioid noncaseating granulomas predominate, and acid-fast bacilli (AFB) are absent or only rarely present. In borderline lepromatous and lepromatous leprosy, the infiltrate is composed of macrophages with a vacuolar cytoplasm, lymphocytes, and plasma cells. AFB are numerous. Edema inside and outside the epithelioid granulomas, together with the appearance of large giant cells, are the main features of type 1 reactions. A conspicuous neutrophilic infiltrate in the subcutis with or without vasculitis is found in erythema nodosum leprosum. The main histopathologic features of leprosy and its particular forms are discussed in this review.
Asunto(s)
Eritema Nudoso/patología , Lepra Dimorfa/patología , Lepra Lepromatosa/patología , Lepra Tuberculoide/patología , Piel/patología , Biopsia con Aguja , Diagnóstico Diferencial , Progresión de la Enfermedad , Eritema Nudoso/fisiopatología , Femenino , Humanos , Inmunohistoquímica , Lepra Dimorfa/fisiopatología , Lepra Lepromatosa/fisiopatología , Lepra Tuberculoide/fisiopatología , Masculino , Recurrencia , Medición de Riesgo , Índice de Severidad de la EnfermedadRESUMEN
Leprosy is a chronic, infectious disease caused by Mycobacterium leprae. It mainly affects the peripheral nervous system, skin, and certain other tissues such as the reticulo-endothelial system, bones and joints, mucous membranes, eyes, testes, muscles, and adrenals. Leprosy clinical presentation varies from few to widespread lesions. In most patients, early leprosy presents as macular and hypopigmented lesions. This initial clinical presentation is known as indeterminate leprosy and occurs in individuals who have not developed cell-mediated immunity against M. leprae yet. The number of lesions depends on the genetically determined cellular immunity of the patient. Individuals presenting a vigorous cellular immune response and limited humoral immune responses to M. leprae, usually present few skin lesions. Without treatment, those patients tend to evolve into the polar tuberculoid or borderline tuberculoid form of leprosy. Due to the inability to mount an effective cellular-mediated response to M. leprae and the consequent hematogenous spread of the bacilli, some patients may present with numerous and symmetrically distributed hypochromic lesions. Without treatment these patients evolve to a nonresistant form of leprosy, polar lepromatous.
Asunto(s)
Progresión de la Enfermedad , Leprostáticos/uso terapéutico , Lepra/mortalidad , Lepra/fisiopatología , Mycobacterium leprae/aislamiento & purificación , Brasil , Enfermedades Transmisibles/tratamiento farmacológico , Enfermedades Transmisibles/epidemiología , Enfermedades Transmisibles/fisiopatología , Femenino , Humanos , Lepra/tratamiento farmacológico , Lepra Dimorfa/tratamiento farmacológico , Lepra Dimorfa/epidemiología , Lepra Dimorfa/fisiopatología , Lepra Lepromatosa/inmunología , Lepra Lepromatosa/fisiopatología , Lepra Tuberculoide/inmunología , Lepra Tuberculoide/fisiopatología , Masculino , Monitoreo Fisiológico , Mycobacterium leprae/inmunología , Pronóstico , Medición de Riesgo , Índice de Severidad de la Enfermedad , Tasa de SupervivenciaAsunto(s)
Clofazimina/administración & dosificación , Dapsona/administración & dosificación , Facies , Lepra Lepromatosa , Mycobacterium leprae , Perforación del Tabique Nasal , Tabique Nasal/patología , Rifampin/administración & dosificación , Humanos , Leprostáticos/administración & dosificación , Lepra Lepromatosa/diagnóstico , Lepra Lepromatosa/tratamiento farmacológico , Lepra Lepromatosa/microbiología , Lepra Lepromatosa/fisiopatología , Masculino , Mycobacterium leprae/efectos de los fármacos , Mycobacterium leprae/aislamiento & purificación , Perforación del Tabique Nasal/diagnóstico , Perforación del Tabique Nasal/etiología , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/etiología , Resultado del Tratamiento , Adulto JovenRESUMEN
OBJECTIVES: To evaluate PSA (Prostate-specific antigen) parameters in patients with lepromatous leprosy (LL). DESIGN: In a retrospective study, 23 male patients with LL were evaluated. PSA parameters (serum total PSA (tPSA), free PSA (fPSA), free-to-total PSA ratio (f/tPSA), PSA Density (PSAD)) were assessed. PSA parameters were compared with a control group. RESULTS: The mean tPSA, fPSA, f/tPSA, prostate volume, and PSAD values of the patient group with LL were 1.87 +/- 0.81 ng/ml, 0.67 +/- 0.29 ng/ml, 0.36 +/- 0.11, 41.08 +/- 23.65 ml and 0.055 +/- 0.037, respectively. The mean tPSA, fPSA, f/tPSA, prostate volume, and PSAD values of the control group were 2.71 +/- 0.91 ng/ml, 0.80 +/- 0.34 ng/ml, 0.30 +/- 0.08, 65.0 +/- 28.73 ml and 0.049 +/- 0.028, respectively. The mean tPSA and prostate volume values were found to be significantly lower in the patient group with LL (p = 0.002 and 0.004, respectively). No significant difference was found between two groups in terms of mean fPSA and PSAD values (p = 0.18 and 0.5, respectively). The mean f/tPSA value was found to be significantly higher in the patient group with LL (p = 0.02). Testes in 16 (69%) patients with LL were bilaterally atrophic. CONCLUSIONS: Serum tPSA values and prostate volumes in the patients with LL were significantly reduced and f/tPSA values were significantly increased. Testicular atrophy in the lepromatous cases might be due to leprosy-related orchitis and associated with a reduction in prostatic volume.
Asunto(s)
Lepra Lepromatosa/patología , Antígeno Prostático Específico/sangre , Próstata/patología , Testículo/patología , Anciano , Anciano de 80 o más Años , Humanos , Lepra Lepromatosa/sangre , Lepra Lepromatosa/fisiopatología , Masculino , Tamaño de los Órganos , Próstata/crecimiento & desarrollo , Estudios RetrospectivosRESUMEN
Hansen's disease (HD) is a chronic granulomatous infectious disease caused by Mycobacterium leprae. The worldwide prevalence rate of HD has decreased gradually over the years. The clinical manifestations of HD are extensive, with involvement of the skin and various organs, and these can resemble those of many rheumatic diseases. Our patient initially presented with gradual sclerotic skin change and slight sclerodactyly with Raynaud's phenomenon, which is frequently observed in systemic sclerosis. However, a skin biopsy with acid-fast stain later confirmed lepromatous leprosy. We report this case to emphasize the role of dermatologists for applying a systematic approach to the skin lesions of HD, which has become difficult to detect because of its rapidly declining prevalence rate.
Asunto(s)
Lepra Lepromatosa/diagnóstico , Esclerodermia Sistémica/diagnóstico , Anciano de 80 o más Años , Errores Diagnósticos , Femenino , Humanos , Lepra Lepromatosa/patología , Lepra Lepromatosa/fisiopatología , Conducción Nerviosa , Polineuropatías/fisiopatología , Piel/patologíaRESUMEN
T regulatory cells (Tregs) play an important role in the mechanism of host's failure to control pathogen dissemination in severe forms of different chronic granulomatous diseases, but their role in leprosy has not yet been elucidated; 28 newly diagnosed patients (16 patients with lepromatous leprosy and 12 patients with tuberculoid leprosy) and 6 healthy Mycobacterium leprae-exposed individuals (contacts) were studied. Tregs were quantified by flow cytometry (CD4+ CD25+ Foxp3+) in peripheral blood mononuclear cells stimulated in vitro with a M. leprae antigenic preparation and phytohemagglutinin as well as in skin lesions by immunohistochemistry. The lymphoproliferative (LPR), interleukin-10 (IL-10), and interferon-γ (IFN-γ) responses of the in vitro-stimulated peripheral blood mononuclear cells and the in situ expression of IL-10, transforming growth factor-ß (TGF-ß), and cytotoxic T-lymphocyte antigen 4 (CTLA-4) were also determined. We show that M. leprae antigens induced significantly lower LPR but significantly higher Treg numbers in lepromatous than tuberculoid patients and contacts. Mitogen-induced LPR and Treg frequencies were not significantly different among the three groups. Tregs were also more frequent in situ in lepromatous patients, and this finding was paralleled by increased expression of the antiinflammatory molecules IL-10 and CTLA-4 but not TGF-ß. In lepromatous patients, Tregs were intermingled with vacuolized hystiocyte infiltrates all over the lesion, whereas in tuberculoid patients, Tregs were rare. Our results suggest that Tregs are present in increased numbers, and they may have a pathogenic role in leprosy patients harboring uncontrolled bacillary multiplication but not in those individuals capable of limiting M. leprae growth.
Asunto(s)
Lepra Lepromatosa/inmunología , Mycobacterium leprae/genética , Mycobacterium leprae/patogenicidad , Linfocitos T Reguladores/metabolismo , Adulto , Antígeno CTLA-4/metabolismo , Estudios de Casos y Controles , Regulación hacia Abajo , Femenino , Regulación Bacteriana de la Expresión Génica , Interacciones Huésped-Patógeno , Humanos , Interferón gamma/metabolismo , Interleucina-10/metabolismo , Lepra Lepromatosa/fisiopatología , Leucocitos Mononucleares/patología , Masculino , Persona de Mediana Edad , Mycobacterium leprae/crecimiento & desarrollo , Factor de Crecimiento Transformador beta/metabolismoRESUMEN
BACKGROUND: Leprosy is a disease of the skin and peripheral nervous system caused by the obligate intracellular bacterium Mycobacterium leprae. The clinical presentations of leprosy are spectral, with the severity of disease determined by the balance between the cellular and humoral immune response of the host. The exact mechanisms that facilitate disease susceptibility, onset and progression to certain clinical phenotypes are presently unclear. Various studies have examined lipid metabolism in leprosy, but there has been limited work using whole metabolite profiles to distinguish the clinical forms of leprosy. METHODOLOGY AND PRINCIPAL FINDINGS: In this study we adopted a metabolomics approach using high mass accuracy ultrahigh pressure liquid chromatography mass spectrometry (UPLC-MS) to investigate the circulatory biomarkers in newly diagnosed untreated leprosy patients. Sera from patients having bacterial indices (BI) below 1 or above 4 were selected, subjected to UPLC-MS, and then analyzed for biomarkers which distinguish the polar presentations of leprosy. We found significant increases in the abundance of certain polyunsaturated fatty acids (PUFAs) and phospholipids in the high-BI patients, when contrasted with the levels in the low-BI patients. In particular, the median values of arachidonic acid (2-fold increase), eicosapentaenoic acid (2.6-fold increase) and docosahexaenoic acid (1.6-fold increase) were found to be greater in the high-BI patients. SIGNIFICANCE: Eicosapentaenoic acid and docosahexaenoic acid are known to exert anti-inflammatory properties, while arachidonic acid has been reported to have both pro- and anti-inflammatory activities. The observed increase in the levels of several lipids in high-BI patients may provide novel clues regarding the biological pathways involved in the immunomodulation of leprosy. Furthermore, these results may lead to the discovery of biomarkers that can be used to investigate susceptibility to infection, facilitate early diagnosis and monitor the progression of disease.
Asunto(s)
Biomarcadores/sangre , Ácidos Grasos Insaturados/sangre , Lepra Lepromatosa/diagnóstico , Lepra Lepromatosa/fisiopatología , Metaboloma , Mycobacterium leprae/patogenicidad , Suero/química , Adulto , Cromatografía Líquida de Alta Presión , Femenino , Humanos , Masculino , Espectrometría de Masas , Persona de Mediana EdadRESUMEN
Erythema nodosum leprosum (ENL) is an inflammatory reaction that may occur in multibacillary leprosy patients, and thalidomide is the treatment of choice. Its cause and the mechanism by which thalidomide suppresses ENL are not known. In the skin lesions, im- mune complexes and split products of complement are found. The activation of complement could precipitate ENL, and thalidomide could suppress the inflammation by inhibiting the activation of complement. To determine if thalidomide could suppress the activation of complement, we first incubated normal serum with thalidomide and with M. leprae or zymosan. The amount of residual functional complement was then assessed by determining the dilution of serum required to lyses sheep erythrocytes sensitized by rabbit antibodies (CH50 Assay). M. leprae and zymosan activated complement. The residual complement activity in the serum incubated with M. leprae or with zymosan was equivalent to that incubated with M. leprae or zymosan in the presence of thalidomide, hydrolyzed thalidomide and metabolites of thalidomide. Thalidomide did not inhibit the activation of complement by zymosan, a known initiator of complement activation by the alternative pathway, or by M. leprae.
Asunto(s)
Activación de Complemento/efectos de los fármacos , Eritema Nudoso/tratamiento farmacológico , Leprostáticos/farmacología , Lepra Lepromatosa/tratamiento farmacológico , Mycobacterium leprae/efectos de los fármacos , Mycobacterium leprae/inmunología , Talidomida/farmacología , Animales , Proteínas del Sistema Complemento/análisis , Eritema Nudoso/inmunología , Eritema Nudoso/fisiopatología , Humanos , Lepra Lepromatosa/inmunología , Lepra Lepromatosa/fisiopatología , Hígado/enzimología , Ratones , Mycobacterium leprae/metabolismo , Conejos , OvinosRESUMEN
We report a case of multiple relapses in a lepromatous leprosy patient after treatment with World Health Organisation (WHO) recommended multibacillary multidrug therapy (MBMDT). The patient responded well to reintroduction of MDT after each relapse.
Asunto(s)
Leprostáticos/uso terapéutico , Lepra Lepromatosa/patología , Lepra Lepromatosa/fisiopatología , Quimioterapia Combinada , Humanos , Lepra Lepromatosa/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Recurrencia , Piel/patologíaRESUMEN
We report a 52 year-old woman with a past history of lepromatous leprosy (14 years prior to our first evaluation) who presented with progressive weakness and severe arm/leg pain. CSF analysis revealed elevated protein level with normal cell count. Skin and sural nerve biopsy showed no bacilli. Immunomodulatory treatment led to major improvement on clinical, CSF and electrodiagnostic grounds, but after one year of treatment, skin test revealed leprosy relapse. To our knowledge, this is the first report of a multifocal inflammatory neuropathy heralding leprosy relapse. Extended neurological work-up may be important in unexplained neuropathy progression after leprosy treatment.
Asunto(s)
Lepra Lepromatosa/fisiopatología , Debilidad Muscular/fisiopatología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Progresión de la Enfermedad , Femenino , Humanos , Inmunoterapia , Lepra Lepromatosa/líquido cefalorraquídeo , Lepra Lepromatosa/tratamiento farmacológico , Persona de Mediana Edad , Debilidad Muscular/líquido cefalorraquídeo , Debilidad Muscular/terapia , Enfermedades del Sistema Nervioso Periférico/líquido cefalorraquídeo , Enfermedades del Sistema Nervioso Periférico/terapia , Recurrencia , Piel/microbiología , Piel/patología , Nervio Sural/microbiología , Nervio Sural/patología , Factores de Tiempo , Resultado del TratamientoRESUMEN
INTRODUCTION: Erythema nodosum leprosum (ENL) is an inflammatory reaction, which may occur in the course of leprosy and may result in nerve function impairment and subsequent disability. METHODS: This retrospective study explores demographic and disease specific parameters. Severity of ENL was assessed using the Reaction Severity Scale (RSS). Records of 94 patients were reviewed. The study reports also on the treatment of 76 of these patients who were treated with prednisolone alone or thalidomide in addition to prednisolone. RESULTS Thirty percent of patients presented with ENL at time of diagnosis; 41% developed ENL-reaction in the first year of MDT. Forty-eight percent of patients were treated for ENL-reaction for less than 12 months; 13% for more than 5 years. High RSS-scores correlated with a longer duration of treatment. In group A (prednisolone) 51.7% and in group B (prednisolone and thalidomide) 76.6% of patients were male. Age, leprosy classification, delay of multidrug treatment (MDT) and interval between MDT and first ENL-symptoms did not differ significantly in both groups. Median duration of ENL-treatment was 15 months in group A versus 38 months in group B (P < 0.001). At the start of treatment, ENL-reaction was less severe in group A (RSS = 12) than in group B (RSS = 18; P = 0.003). DISCUSSION: ENL-symptoms may be of help in the early diagnosis and adequate treatment of ENL. Characterisation of (sub) groups of patients with ENL based on presence and severity of symptoms is important for future prospective studies to better evaluate the efficacy of interventions.
Asunto(s)
Antiinflamatorios/uso terapéutico , Eritema Nudoso , Leprostáticos/uso terapéutico , Lepra Lepromatosa , Prednisolona/uso terapéutico , Talidomida/uso terapéutico , Adolescente , Adulto , Anciano , Niño , Eritema Nudoso/tratamiento farmacológico , Eritema Nudoso/microbiología , Eritema Nudoso/fisiopatología , Femenino , Humanos , Lepra Lepromatosa/tratamiento farmacológico , Lepra Lepromatosa/microbiología , Lepra Lepromatosa/fisiopatología , Masculino , Persona de Mediana Edad , Mycobacterium leprae/efectos de los fármacos , Nepal , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Adulto JovenRESUMEN
BACKGROUND: Although a few studies have shown fine needle aspiration cytology (FNAC) to be a sensitive diagnostic tool in the detection of nerve involvement, its role as an initial diagnostic procedure in pure neuritic leprosy (PNL) and in the detection of skeletal lesions with unusual findings has not been documented before. CASES: Three patients who presented with thickened nerves and a fourth with biopsy-proven lepromatous leprosy with lesions in hand bones underwent FNAC. Of the 3 patients with nerve thickening, 2 had a clinical suspicion or diagnosis of neuritic leprosy, whereas in the third patient a clinical differential diagnosis of a soft tissue tumor or parasitic cyst was considered. FNAC in all 3 cases revealed epithelioid cell granulomas, Langhans giant cells and caseous necrosis. Fites and Ziehl-Neelsen stains were negative for acid-fast bacilli. Cytologic diagnosis of pure neuritic leprosy was made in all 3 cases and confirmed by histopathologic examination. FNAC of skeletal lesions from the fourth patient confirmed involvement of bone with unusual cytologic findings of epithelioid cell granulomas and giant cells along with a significant proportion of foamy macrophages and strong Fites stain positivity. CONCLUSION: FNAC is a simple, useful, minimally traumatic and routinely applicable procedure in the diagnosis of pure neuritic leprosy and leprous osteitis.